chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Tenderness, Vaccination site pain
Clinical narrative: Tenderness; Feels sleepy all day; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), SOMNOLENCE (Feels sleepy all day) and VACCINATION SITE PAIN (Pain at injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026CZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Bee sting (Bee stings) and Drug allergy (Multiple allergies to medications (she don't have a list)). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), SUPER B COMPLEX WITH C, GINKGO BILOBA (GINGKO BILOBA), COLECALCIFEROL, UBIDECARENONE (COQ10 + D3), VITAMIN D3, CENTRUM SILVER +50, GLUCOSAMINE, EMERGEN C, ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +), VITIS VINIFERA EXTRACT (GRAPESEED), METOPROLOL, IRON and LOSARTAN for an unknown indication.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced TENDERNESS (Tenderness), SOMNOLENCE (Feels sleepy all day) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram once. At the time of the report, TENDERNESS (Tenderness), SOMNOLENCE (Feels sleepy all day) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient also reported other concomitant medications that include Garlic capsule, Aller-tec 1 tab once daily.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Hypersensitivity, Myalgia, Nasopharyngitis
Clinical narrative: Nose dripping; Feeling hot; Feel like they have a bad cold; Feel like they have a bad allergies; Cold chills; Right arm very sore; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies) and CHILLS (Cold chills) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2021.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies), CHILLS (Cold chills) and MYALGIA (Right arm very sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies), CHILLS (Cold chills) and MYALGIA (Right arm very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication includes blood thinner and the patient was on a lot of daily medications but did not felt like going through them  at this time.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Nose dripping; Feeling hot; Feel like they have a bad cold; Feel like they have a bad allergies; Cold chills; Right arm very sore; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies) and CHILLS (Cold chills) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2021.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies), CHILLS (Cold chills) and MYALGIA (Right arm very sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Nose dripping), FEELING HOT (Feeling hot), NASOPHARYNGITIS (Feel like they have a bad cold), HYPERSENSITIVITY (Feel like they have a bad allergies), CHILLS (Cold chills) and MYALGIA (Right arm very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication includes blood thinner and the patient was on a lot of daily medications but did not felt like going through them  at this time.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: low grade fever after second dose; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever after second dose) and HEADACHE (slight headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, GERD, Anaemia and Restless leg syndrome. Concomitant products included FERROUS GLUCONATE (POLY-IRON [FERROUS GLUCONATE]) for Anaemia, OMEPRAZOLE for GERD, ATORVASTATIN for High cholesterol, CLONAZEPAM for Restless leg syndrome.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (low grade fever after second dose) and HEADACHE (slight headache). On 25-Feb-2021, PYREXIA (low grade fever after second dose) and HEADACHE (slight headache) had resolved.            Treatment information was not provided.   This case was linked to MOD-2021-298189 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Reporter contact info, patient demographics updated, medical  history, first dose batch no and concomitant were added,
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: How can I complete my vaccination; Got COVID-19 two days after receiving Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID-19 two days after receiving Moderna vaccine) and PRODUCT DOSE OMISSION ISSUE (How can I complete my vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced COVID-19 (Got COVID-19 two days after receiving Moderna vaccine). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (How can I complete my vaccination). At the time of the report, COVID-19 (Got COVID-19 two days after receiving Moderna vaccine) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (How can I complete my vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red; itches terribly; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PRURITUS (itches terribly) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PRURITUS (itches terribly). At the time of the report, VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PRURITUS (itches terribly) outcome was unknown.            No concomitant medication  was reported.  No treatment history was reported.   This case was linked to MOD-2021-298586, MOD-2021-298603 (Patient Link).   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Joint swelling, Pain in extremity, Surgery
Clinical narrative: 3rd dose 26 of Aug 2021; soreness in his arm; swelling without pain in his ankles on the bottom of his legs /  I had severe swelling of both ankles.; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling without pain in his ankles on the bottom of his legs /  I had severe swelling of both ankles.), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose 26 of Aug 2021) and PAIN IN EXTREMITY (soreness in his arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028l20a, 053e21a and 039k20a) for COVID-19 vaccination.     The patient's past medical history included Thyroid cancer in April 2021 and Kidney stones. Concurrent medical conditions included Sarcoidosis and Diabetes. Concomitant products included METHOTREXATE and PREDNISONE for Arthritis, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for Breathing difficult, GLIPIZIDE and GEFITINIB (B-D NANO 2ND GEN NEEDLE) for Diabetes, METHYLPHENIDATE for Narcolepsy, TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN [TAMSULOSIN HYDROCHLORIDE]) for Urination pain, AMLODIPINE, ATORVASTATIN, FOLIC ACID, LOSARTAN, OMEPRAZOLE, ZOLEDRONIC ACID from 20-Aug-2021 to an unknown date, LEVOTHYROXINE SODIUM (SYNTHROID), BROMAZEPAM (TENSONIL), TRAZODONE, ESCITALOPRAM OXALATE (LEXAPRO), TRAZODONE HYDROCHLORIDE (TRAZODONE [TRAZODONE HYDROCHLORIDE]), EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA) and AMLODIPINE for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced JOINT SWELLING (swelling without pain in his ankles on the bottom of his legs /  I had severe swelling of both ankles.). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose 26 of Aug 2021) and PAIN IN EXTREMITY (soreness in his arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, JOINT SWELLING (swelling without pain in his ankles on the bottom of his legs /  I had severe swelling of both ankles.) and PAIN IN EXTREMITY (soreness in his arm) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose 26 of Aug 2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Surgery: unknown (Inconclusive) thyroid cancer removed.         This case was linked to MOD-2021-299975 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Significant follow up appended :Concomitant Drugs
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose less than 28 days; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose less than 28 days) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose less than 28 days). On 28-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose less than 28 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received on 01-SEP-2021. No new information
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Headache, Pruritus
Clinical narrative: Took the shot felt a burning itching flowing through veins down into wrist; Felt a fiery itch flowing into and around heart.; Had a sudden onset stabbing headache on right forehead; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Took the shot felt a burning itching flowing through veins down into wrist), PRURITUS (Felt a fiery itch flowing into and around heart.) and HEADACHE (Had a sudden onset stabbing headache on right forehead) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Took the shot felt a burning itching flowing through veins down into wrist), PRURITUS (Felt a fiery itch flowing into and around heart.) and HEADACHE (Had a sudden onset stabbing headache on right forehead). At the time of the report, BURNING SENSATION (Took the shot felt a burning itching flowing through veins down into wrist), PRURITUS (Felt a fiery itch flowing into and around heart.) and HEADACHE (Had a sudden onset stabbing headache on right forehead) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  No Treatment information was reported.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: First two doses administered were Pfizer but today the patient received a Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (First two doses administered were Pfizer but today the patient received a Moderna vaccine) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE (First two doses.).    On 28-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (First two doses administered were Pfizer but today the patient received a Moderna vaccine). On 28-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (First two doses administered were Pfizer but today the patient received a Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Got COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID-19). At the time of the report, COVID-19 (Got COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment information was reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: could not taste the coke/ lost sense of taste; lost sense of smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (could not taste the coke/ lost sense of taste) and ANOSMIA (lost sense of smell) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Norco allergy).    On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Aug-2021, the patient experienced AGEUSIA (could not taste the coke/ lost sense of taste) and ANOSMIA (lost sense of smell). At the time of the report, AGEUSIA (could not taste the coke/ lost sense of taste) and ANOSMIA (lost sense of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment was reported.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site mass
Clinical narrative: She has a knot on the arm at the injection site; Itches like when you get a cut and it starts to heal; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Aug-2021 and was forwarded to Moderna on 29-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (She has a knot on the arm at the injection site) and PRURITUS (Itches like when you get a cut and it starts to heal) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 035C21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE) for an unknown indication.   On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced VACCINATION SITE MASS (She has a knot on the arm at the injection site) and PRURITUS (Itches like when you get a cut and it starts to heal). At the time of the report, VACCINATION SITE MASS (She has a knot on the arm at the injection site) and PRURITUS (Itches like when you get a cut and it starts to heal) outcome was unknown.            No treatment medications were provided.   This case was linked to MOD-2021-300288 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Chills, Decreased appetite, Gait disturbance
Clinical narrative: no energy; Woke up at 2 am with shivering; aching all over; Burning up; Couldn't move/Barely made it to the bathroom/sat in one position; Could not go back to sleep; Couldn't eat or drink/ Didn't want anything to drink or eat; Couldn't easily walk; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat) and GAIT DISTURBANCE (Couldn't easily walk) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Heart disorder, Constipation and Hypercholesteraemia. Concomitant products included AMLODIPINE for Blood pressure high, MAGNESIUM CITRATE for Constipation, ACETYLSALICYLIC ACID (ASPIRIN 81) for Heart disorder, PITAVASTATIN CALCIUM (PIVASTA) for Hypercholesteraemia, EZETIMIBE for Hypercholesterolaemia.   On 21-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021 at 4:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat), GAIT DISTURBANCE (Couldn't easily walk), CHILLS (Woke up at 2 am with shivering) and MYALGIA (aching all over). On 20-Feb-2021, the patient experienced ASTHENIA (no energy). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg. On 21-Feb-2021, BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat), GAIT DISTURBANCE (Couldn't easily walk), ASTHENIA (no energy), CHILLS (Woke up at 2 am with shivering) and MYALGIA (aching all over) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up received contains significant information- Patient's race, ethnicity, concomitant, treatment medications and dosage regimen.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Mobility decreased, Myalgia
Clinical narrative: no energy; Woke up at 2 am with shivering; aching all over; Burning up; Couldn't move/Barely made it to the bathroom/sat in one position; Could not go back to sleep; Couldn't eat or drink/ Didn't want anything to drink or eat; Couldn't easily walk; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat) and GAIT DISTURBANCE (Couldn't easily walk) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Heart disorder, Constipation and Hypercholesteraemia. Concomitant products included AMLODIPINE for Blood pressure high, MAGNESIUM CITRATE for Constipation, ACETYLSALICYLIC ACID (ASPIRIN 81) for Heart disorder, PITAVASTATIN CALCIUM (PIVASTA) for Hypercholesteraemia, EZETIMIBE for Hypercholesterolaemia.   On 21-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021 at 4:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat), GAIT DISTURBANCE (Couldn't easily walk), CHILLS (Woke up at 2 am with shivering) and MYALGIA (aching all over). On 20-Feb-2021, the patient experienced ASTHENIA (no energy). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg. On 21-Feb-2021, BURNING SENSATION (Burning up), MOBILITY DECREASED (Couldn't move/Barely made it to the bathroom/sat in one position), INSOMNIA (Could not go back to sleep), DECREASED APPETITE (Couldn't eat or drink/ Didn't want anything to drink or eat), GAIT DISTURBANCE (Couldn't easily walk), ASTHENIA (no energy), CHILLS (Woke up at 2 am with shivering) and MYALGIA (aching all over) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up received contains significant information- Patient's race, ethnicity, concomitant, treatment medications and dosage regimen.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Unspecific AE; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unspecific AE) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unspecific AE). At the time of the report, VACCINATION COMPLICATION (Unspecific AE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not  provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dental discomfort, Headache, Nasal congestion, Nasal pruritus, Ocular discomfort
Clinical narrative: like hay fever; pressure behind the eyes; congestion feeling across the bridge of the nose; pressure in the teeth; nose was itching; runny nose; headache; This spontaneous case was reported by a consumer and describes the occurrence of SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth) and NASAL PRURITUS (nose was itching) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Urinary tract infection.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth), NASAL PRURITUS (nose was itching), RHINORRHOEA (runny nose) and HEADACHE (headache). The patient was treated with CEFALEXIN (CEPHALEXINE) on 10-Aug-2021 for Urinary tract infection, at a dose of UNK, 7 days; VITAMINS NOS ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency and XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth), NASAL PRURITUS (nose was itching), RHINORRHOEA (runny nose) and HEADACHE (headache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications also included Allergy release medicine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Seasonal allergy
Clinical narrative: like hay fever; pressure behind the eyes; congestion feeling across the bridge of the nose; pressure in the teeth; nose was itching; runny nose; headache; This spontaneous case was reported by a consumer and describes the occurrence of SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth) and NASAL PRURITUS (nose was itching) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Urinary tract infection.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth), NASAL PRURITUS (nose was itching), RHINORRHOEA (runny nose) and HEADACHE (headache). The patient was treated with CEFALEXIN (CEPHALEXINE) on 10-Aug-2021 for Urinary tract infection, at a dose of UNK, 7 days; VITAMINS NOS ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency and XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SEASONAL ALLERGY (like hay fever), OCULAR DISCOMFORT (pressure behind the eyes), NASAL CONGESTION (congestion feeling across the bridge of the nose), DENTAL DISCOMFORT (pressure in the teeth), NASAL PRURITUS (nose was itching), RHINORRHOEA (runny nose) and HEADACHE (headache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications also included Allergy release medicine.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (sulfa drugs), Penicillin allergy, Major depression, Anemia, Hiatal hernia and Insomnia. Concomitant products included BUPROPION for Depression, TRAZODONE for Insomnia.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose). On 30-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported. Patient's race is black. Patient's height is 66.14 inches. Patient received the vaccine on 30th Aug 2021 at 08:45 am. This report refers to a case of Product storage error for mRNA-1273, lot # 014C21A  with no associated AEs.   Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up received: reporters information , patient's demographic, concurrent condition of the patient and concomitant medication were updated.; Sender's Comments: This report refers to a case of Product storage error for mRNA-1273, lot # 014C21A  with no associated AEs.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dementia, Mania, Vaccination complication
Clinical narrative: Suffered severe incident twice; Dementia; Showing a maniac behavior; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffered severe incident twice), DEMENTIA (Dementia) and MANIA (Showing a maniac behavior) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D2LA) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Blood pressure high. Concomitant products included HYDROCHLOROTHIAZIDE and SPIRONOLACTONE for Blood pressure high, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.    On 28-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced DEMENTIA (Dementia). 29-Aug-2021, the patient experienced MANIA (Showing a maniac behavior). On an unknown date, the patient experienced VACCINATION COMPLICATION (Suffered severe incident twice). On 29-Aug-2021, DEMENTIA (Dementia) and MANIA (Showing a maniac behavior) had resolved. At the time of the report, VACCINATION COMPLICATION (Suffered severe incident twice) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided.   This case was linked to MOD-2021-301073, MOD-2021-300955 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Adverse event updated to suffered severe incident twice On 03-Sep-2021: Follow-up received on 03-Sep-2021 and No New Information is provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 242 patients were administered expired doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (242 patients were administered expired doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (242 patients were administered expired doses). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (242 patients were administered expired doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.  Lot numbers and their following expiration date:   1. 001C21A (12Oct2021)  2. 011A21A (16Aug2021)  3. 011M202A (16July2021)  4. 027C21A (18Sept2021)  5. 031A21A (28Aug2021)  6. 041B21A (4Oct2021)
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Muscular weakness, Vaccination site pain
Clinical narrative: lack of energy/their strength in the right hand is gone; The weakness in the right hand is moving up their arm to their elbow now; the patient fatigues real easy now; left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concurrent medical conditions included Seizures, Pain and Paralyzed (Left side of their body is paralyzed.). Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Pain, PHENYTOIN for Seizures, PANTOPRAZOLE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ESCITALOPRAM and LOVASTATIN for an unknown indication.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out). At the time of the report, ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was reported.   Reporter did not allow further contact
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Lethargy, Pain in extremity
Clinical narrative: Lethargic; Headache; fatigue; Coughing; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), COUGH (Coughing), HEADACHE (Headache), FATIGUE (fatigue) and MYALGIA (sore arm) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced MYALGIA (sore arm). On 25-Aug-2021, the patient experienced COUGH (Coughing). On 26-Aug-2021, the patient experienced LETHARGY (Lethargic), HEADACHE (Headache) and FATIGUE (fatigue). In August 2021, MYALGIA (sore arm) had resolved. At the time of the report, LETHARGY (Lethargic), COUGH (Coughing), HEADACHE (Headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Slight headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Slight headache). At the time of the report, HEADACHE (Slight headache) outcome was unknown.            No Concomitant medication information was reported. No treatment medications were provided.   This case was linked to MOD-2021-301391, MOD-2021-301391 (Patient Link).   Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was reported by reporter.  Crosslinked to MOD21-137073
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired doses today 30Aug2021, The use-by date was 27Aug2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021). On 30-Aug-2021, EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Myalgia, Pain in extremity
Clinical narrative: arthritis in my joints; pain in my arms; It feels muscular, pain in the muscles of the upper arm pain the in muscles of the lower arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (arthritis in my joints), PAIN IN EXTREMITY (pain in my arms) and MYALGIA (It feels muscular, pain in the muscles of the upper arm pain the in muscles of the lower arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced ARTHRITIS (arthritis in my joints), PAIN IN EXTREMITY (pain in my arms) and MYALGIA (It feels muscular, pain in the muscles of the upper arm pain the in muscles of the lower arm). At the time of the report, ARTHRITIS (arthritis in my joints), PAIN IN EXTREMITY (pain in my arms) and MYALGIA (It feels muscular, pain in the muscles of the upper arm pain the in muscles of the lower arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was stated The patient has always exercised regularly. Prior to receiving the vaccine, patient was doing 100 pushups several times a week. She was using an 8 lb weight to bend over and up strengthening her arms. patient did a walk/run about three miles several times a week.  No Concomitant medication was provided. No Treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Sep-2021: Follow-up information include patient demographics details, new events, event start date and outcome updated.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination complication
Clinical narrative: Reported a side effect; I have the three of moderna but I'M NOT TAKE 8 MONTH FOR THE SECOND; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reported a side effect) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have the three of moderna but I'M NOT TAKE 8 MONTH FOR THE SECOND) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reported a side effect) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have the three of moderna but I'M NOT TAKE 8 MONTH FOR THE SECOND). At the time of the report, VACCINATION COMPLICATION (Reported a side effect) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have the three of moderna but I'M NOT TAKE 8 MONTH FOR THE SECOND) had resolved.            No concomitant medication was reported.                   No treatment medication was reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Illness, Vaccination complication
Clinical narrative: Can I start feeling side effects an hour after the 2nd dose?; Can I get sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Can I start feeling side effects an hour after the 2nd dose?) and ILLNESS (Can I get sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Can I start feeling side effects an hour after the 2nd dose?) and ILLNESS (Can I get sick). At the time of the report, VACCINATION COMPLICATION (Can I start feeling side effects an hour after the 2nd dose?) and ILLNESS (Can I get sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported by reporter. Treatment information was not provided by reporter
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Myalgia, Rash, Vaccination site reaction
Clinical narrative: covid arm; soreness with red and hot muscle; soreness with red and hot muscle; rash down the arm; soreness with red and hot muscle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), ERYTHEMA (soreness with red and hot muscle), FEELING HOT (soreness with red and hot muscle), RASH (rash down the arm) and MYALGIA (soreness with red and hot muscle) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm), ERYTHEMA (soreness with red and hot muscle), FEELING HOT (soreness with red and hot muscle), RASH (rash down the arm) and MYALGIA (soreness with red and hot muscle). At the time of the report, VACCINATION SITE REACTION (covid arm), ERYTHEMA (soreness with red and hot muscle), FEELING HOT (soreness with red and hot muscle), RASH (rash down the arm) and MYALGIA (soreness with red and hot muscle) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided.   This case was linked to MOD-2021-302001 (Patient Link).